facebook
twitter
rss
account
search
search
Headlines

New B cell lymphoma therapy is presented

HOUSTON, Dec. 15 (UPI) -- U.S. medical scientists say they've found indolent B cell lymphoma patients respond well to a new three-drug combination therapy.

Supplements don't prevent prostate cancer

HOUSTON , Dec. 10 (UPI) -- Selenium and vitamin E taken alone or in combination for an average of 5 1/2 years did not prevent prostate cancer, U.S. researchers said.

Diet, exercise help old cancer survivors

HOUSTON, Nov. 19 (UPI) -- A portion-controlled diet and exercise improve body weight and physical function in elderly cancer survivors, U.S. researchers have learned.

Genes may alter esophageal cancer risk

HOUSTON, Nov. 6 (UPI) -- U.S. cancer scientists say they have found variations in a common gene pathway can affect esophageal cancer risk.

New cancer drug is called impressive

GENEVA, Switzerland, Oct. 23 (UPI) -- U.S. scientists say an early trial of a multi-kinase inhibitor has shown impressive tumor shrinkage in patients with a hard-to-treat form of thyroid cancer.

New delivery system hikes vaccine response

AUSTIN, Texas, Oct. 13 (UPI) -- U.S. scientists say they've developed a delivery system that could lead to more efficient and more disease-specific vaccines.

No radiation for some breast cancer

BOSTON, Sept. 25 (UPI) -- Early-stage breast cancer patients with limited lymph node involvement may not require post-surgery radiation therapy, U.S. researchers said.

Non-invasive bladder cancer test uses gene

HOUSTON, Sept. 24 (UPI) -- Counting the copies of a specific gene in cells from a urine sample may provide a simple, non-invasive way to detect bladder cancer, U.S. researchers said.

Black women less likely to get radiation

HOUSTON, Sept. 11 (UPI) -- African-American women with breast cancer who have a lumpectomy are less likely to receive radiation compared to white women, U.S. researchers said.

Protein found to suppress skin cancer

HOUSTON, Sept. 10 (UPI) -- U.S. scientists say they've determined the protein IKKalpha suppresses skin cancer development.

Racial lung cancer models aid predictions

HOUSTON, Sept. 9 (UPI) -- U.S. medical scientists say they've developed the first lung cancer risk model for African-Americans.

African-American COPD links to lung cancer

HOUSTON, Sept. 7 (UPI) -- U.S. researchers say African-Americans with a prior history of chronic obstructive pulmonary disease had a six-fold increased risk of lung cancer.

Breast cancer patients still face risk

HOUSTON, Aug. 13 (UPI) -- Breast cancer survivors may still have a substantial risk of disease recurrence five years after treatment, Houston researchers warn.

Protein found to promote DNA repair

SMITHVILLE, Texas, July 22 (UPI) -- A chromosomal protein that binds to damaged DNA prevents cancer development by enhancing DNA repair, Houston researchers said.

Blood vessel drug may treat thyroid cancer

HOUSTON, July 8 (UPI) -- U.S. medical scientists say an experimental drug that inhibits tumor blood vessel growth shows promise in slowing progression of metastatic thyroid cancer.
Prev
Page 1 of 9
Wiki

The University of Texas M. D. Anderson Cancer Center is one of the nation's original three comprehensive cancer centers established by the National Cancer Act of 1971. It is both a degree-granting academic institution and a cancer treatment and research center located in the Texas Medical Center in Houston, Texas. For six of the past eight years, M. D. Anderson has ranked No. 1 in cancer care in the "America's Best Hospitals" survey published in U.S. News & World Report.

M. D. Anderson was created by an act of the Texas Legislature in 1941, making it a component of The University of Texas System. Today it is one of 40 Comprehensive Cancer Centers designated by the National Cancer Institute. The cancer center expects to see more than 90,000 patients this year and employs more than 17,000 people.

The cancer center is named after Monroe Dunaway Anderson, a banker and cotton trader from Jackson, Tennessee. He was a member of a business partnership with his brother-in-law Will Clayton. Their company became the largest cotton company in the world. Anderson feared that, in the event of one of the partners' deaths, the company would lose a large amount of money to estate tax and be forced to dissolve. To avoid this, Anderson created the M.D. Anderson Foundation with an initial sum of $300,000. In 1939 after Anderson's death, the foundation received $19 million.

This article is licensed under the GNU Free Documentation License.
It uses material from the Wikipedia article "M. D. Anderson."
Most Popular
x
Feedback